Mixed connective tissue disease laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Line 11: | Line 11: | ||
**Antibodies against the U1-ribonucleoprotein complex (anti U1RNP) | **Antibodies against the U1-ribonucleoprotein complex (anti U1RNP) | ||
**Rheumatoid factor (RF) | **Rheumatoid factor (RF) | ||
**High CRP levels<ref name="pmid9802936">{{cite journal |vauthors=Bakri Hassan A, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I |title=Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease |journal=J. Autoimmun. |volume=11 |issue=5 |pages=503–8 |date=October 1998 |pmid=9802936 |doi=10.1006/jaut.1998.0236 |url=}}</ref> | |||
**Hypergammaglobulinemia<ref name="pmid8480140">{{cite journal |vauthors=Hämeenkorpi R, Ruuska P, Forsberg S, Tiilikainen R, Mäkitalo R, Hakala M |title=More evidence of distinctive features of mixed connective tissue disease |journal=Scand. J. Rheumatol. |volume=22 |issue=2 |pages=63–8 |date=1993 |pmid=8480140 |doi= |url=}}</ref> | **Hypergammaglobulinemia<ref name="pmid8480140">{{cite journal |vauthors=Hämeenkorpi R, Ruuska P, Forsberg S, Tiilikainen R, Mäkitalo R, Hakala M |title=More evidence of distinctive features of mixed connective tissue disease |journal=Scand. J. Rheumatol. |volume=22 |issue=2 |pages=63–8 |date=1993 |pmid=8480140 |doi= |url=}}</ref> | ||
==References== | ==References== |
Revision as of 18:37, 2 April 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease laboratory tests On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease laboratory tests |
Mixed connective tissue disease laboratory tests in the news |
Directions to Hospitals Treating Mixed connective tissue disease |
Risk calculators and risk factors for Mixed connective tissue disease laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Laboratory Findings
References
- ↑ Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K (July 2006). "Rheumatoid factor isotypes in mixed connective tissue disease". Clin. Rheumatol. 25 (4): 572–4. doi:10.1007/s10067-005-0185-y. PMID 16391886.
- ↑ Ruiz Pombo M, Labrador Horrillo M, Selva O'Callaghan A (November 2004). "[Undifferentiated, overlapping and mixed connective tissue diseases]". Med Clin (Barc) (in Spanish; Castilian). 123 (18): 712–7. PMID 15563821.
- ↑ Bakri Hassan A, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I (October 1998). "Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease". J. Autoimmun. 11 (5): 503–8. doi:10.1006/jaut.1998.0236. PMID 9802936.
- ↑ Hämeenkorpi R, Ruuska P, Forsberg S, Tiilikainen R, Mäkitalo R, Hakala M (1993). "More evidence of distinctive features of mixed connective tissue disease". Scand. J. Rheumatol. 22 (2): 63–8. PMID 8480140.